SanFrancisco-based goBalto has entered a strategic partnership with Genexion, a CRO that has selected Tracker, goBalto's web-based clinical trials platform, for its clinical research study start-up and monitoring.
"Interest in Tracker has been strong, and we expect to announce some significant partnerships in the near future to help drive industry-wide acceptance of this technology," said Jae Chung, founder and CEO of goBalto.
Tracker, launched in June 2011, is the first purpose-built Software-as-a-Service clinical research tool that enables clinical trials sponsors and CROs to collaborate with multiple partners directly from the web in a transparent and regulatory compliant manner.
"A good start-up is key to the success of any clinical trial. With Tracker, we are now in full control of this critical phase," said Dr. Yves Grumser, CEO of Genexion. "With fewer resources, we can now identify potential start-up gaps earlier, focus on sites that need more support, share up-to-date information among all stakeholders and report accurate and up-to-date project tracking information to our clients. Tracker has changed the way we are managing trials."